133 related articles for article (PubMed ID: 16569974)
1. Hemostatic responses to resistance training in patients with coronary artery disease.
deJong AT; Womack CJ; Perrine JA; Franklin BA
J Cardiopulm Rehabil; 2006; 26(2):80-3. PubMed ID: 16569974
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolytic responses to manual versus automated snow removal.
Womack CJ; Paton CM; Coughlin AM; Nagelkirk P; Dejong AT; Anderson J; Franklin BA
Med Sci Sports Exerc; 2003 Oct; 35(10):1755-9. PubMed ID: 14523316
[TBL] [Abstract][Full Text] [Related]
3. Changes in von Willebrand factor and fibrinolysis following a post-exercise cool-down.
Paton CM; Nagelkirk PR; Coughlin AM; Cooper JA; Davis GA; Hassouna H; Pivarnik JM; Womack CJ
Eur J Appl Physiol; 2004 Jul; 92(3):328-33. PubMed ID: 15098129
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
5. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
Eriksson-Berg M; Egberg N; Eksborg S; Schenck-Gustafsson K
Thromb Res; 2002 Mar; 105(6):481-6. PubMed ID: 12091046
[TBL] [Abstract][Full Text] [Related]
6. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG
Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644
[TBL] [Abstract][Full Text] [Related]
7. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.
Bridges AB; McLaren M; Scott NA; Pringle TH; McNeill GP; Belch JJ
Br Heart J; 1993 Feb; 69(2):121-4. PubMed ID: 8435236
[TBL] [Abstract][Full Text] [Related]
8. Effects of cardiac rehabilitation on fibrinolysis in patients with coronary artery disease.
Anomasiri W; Thongthawee B
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S242-8. PubMed ID: 16623036
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus.
Mansfield MW; Heywood DM; Grant PJ
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):160-4. PubMed ID: 8548417
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic responses to acute physical activity in older hypertensive men.
DeSouza CA; Dengel DR; Rogers MA; Cox K; Macko RF
J Appl Physiol (1985); 1997 Jun; 82(6):1765-70. PubMed ID: 9173939
[TBL] [Abstract][Full Text] [Related]
11. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
12. Human gender differences in fibrinolytic responses to exercise training and their determinants.
Kulaputana O; Macko RF; Ghiu I; Phares DA; Goldberg AP; Hagberg JM
Exp Physiol; 2005 Nov; 90(6):881-7. PubMed ID: 16118237
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction.
Fernhall B; Szymanski LM; Gorman PA; Milani J; Paup DC; Kessler CM
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1106-13. PubMed ID: 9194761
[TBL] [Abstract][Full Text] [Related]
14. Regular Resistance Training Enhances Fibrinolytic Potential but Does Not Affect Coagulation.
Nagelkirk PR; Soave K; Altherr C; Del Pozzi A
Med Sci Sports Exerc; 2021 Nov; 53(11):2318-2323. PubMed ID: 34115732
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic responses to moderate intensity exercise. Comparison of physically active and inactive men.
Szymanski LM; Pate RR
Arterioscler Thromb; 1994 Nov; 14(11):1746-50. PubMed ID: 7947599
[TBL] [Abstract][Full Text] [Related]
17. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE
Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149
[TBL] [Abstract][Full Text] [Related]
19. Association of blood pressure with fibrinolytic potential in the Framingham offspring population.
Poli KA; Tofler GH; Larson MG; Evans JC; Sutherland PA; Lipinska I; Mittleman MA; Muller JE; D'Agostino RB; Wilson PW; Levy D
Circulation; 2000 Jan; 101(3):264-9. PubMed ID: 10645922
[TBL] [Abstract][Full Text] [Related]
20. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.
Mukamal KJ; Jadhav PP; D'Agostino RB; Massaro JM; Mittleman MA; Lipinska I; Sutherland PA; Matheney T; Levy D; Wilson PW; Ellison RC; Silbershatz H; Muller JE; Tofler GH
Circulation; 2001 Sep; 104(12):1367-73. PubMed ID: 11560851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
